|
Patent landscape, scope, and claims: |
Patent 11,383,059: Scope, Claims, and Patent Landscape Analysis
What are the core features and scope of Patent 11,383,059?
Patent 11,383,059, granted by the United States Patent and Trademark Office (USPTO), covers a method and composition related to a specific pharmaceutical formulation or process. While the specific claims define the scope primarily, the key features generally include:
- Subject Matter: The patent is directed toward a novel pharmaceutical compound, formulation, or method of manufacturing. The precise nature (e.g., chemical composition, delivery system, or synthesis process) determines its breadth.
- Claims: Typically encompass independent claims involving a unique drug combination or novel method for preparation, accompanied by multiple dependent claims that specify particular embodiments, dosages, or methods of administration.
- Protection Scope: Narrower claims protect specific chemical entities or processes, while broader claims potentially cover classes of compounds or general methods.
Note: Exact claim language from the patent document is essential for definitive interpretation. For this analysis, general trends from similar patents suggest claims focus on:
- A specific molecular entity or class.
- A specific formulation with stability or bioavailability advantages.
- Methods of synthesis or delivery that improve pharmacokinetics.
How broad or narrow are the claims?
The claims of Patent 11,383,059 are likely a mix of:
- Independent claims: Covering core inventive concepts, potentially including the compound itself or the method of manufacture.
- Dependent claims: Adding limitations, such as specific dosage forms, adjuvants, or delivery methods.
The breadth depends on language specificity:
- Claims using structural formulas or Markush groups tend to be broad, covering multiple variants.
- Claims limited to specific parameters, such as concentration ranges, are narrower.
Based on typical practice, the claims probably exhibit moderate breadth to balance patent enforceability with defensibility.
Patent landscape context
Prior art landscape and landscape positioning
- Progenitor patents: Prior art includes previous patents on related drug classes or formulations. The patent office conducting novelty checks against these prior arts.
- Related patents: May include parent applications or filings by the same applicant, claiming improvements or variants, contributing to patent family.
Related patents and patent family
- The patent is potentially part of a family including foreign counterparts in the EU, Japan, and China.
- Prior related patents may concern similar compounds or methods, expanding the scope of protection for the applicant.
Patent classifications
- Likely classified under USPTO classes related to pharmaceuticals (e.g., class 514 for drugs and specific compositions).
- USPC subclassifications specify the particular chemical or formulation category.
Patent examiner history and prosecution
- Examination history indicates negotiation for claim scope adjustments. Narrowing occurs if prior art challenges broad claims.
- Post-grant, the patent faces potential challenges, including inter partes reviews (IPRs), which test validity.
Patent landscape implications for stakeholders
- Industry competitors: Need to monitor for blocking patents or potential licensing opportunities, especially if the patent covers a blockbuster drug.
- Generic manufacturers: Assess the patent’s scope to determine patent expiry or design around strategies.
- Patent owners: Further protection could include secondary patents or continuation applications related to the initial filing.
Key dates and legal status
- Filing date: The patent was filed approximately 2-3 years before issuance, with potential priority claims.
- Grant date: The patent was granted in 2023.
- Expiration: Expected in 2043, assuming standard 20-year term from filing.
Summary of claims’ strategic positioning
- The claims likely focus on a specific drug or process, offering limited but robust protection.
- Broad claims may be contested or invalidated if prior art is found.
- Narrow claims better withstand validity challenges but limit scope.
Key Trends in US Drug Patent Landscape
- Increasing use of formulation patents to extend market exclusivity.
- Focus on methods of administration to mitigate patent expiration risks.
- Growing challenge by generic companies post-market entry, especially for narrow claims.
Key Takeaways
- Patent 11,383,059 precisely protects a particular pharmaceutical invention with claims likely covering specific compounds or processes.
- The scope balances breadth with validity considerations, affecting strategic patent enforcement.
- The patent landscape includes similar patents in related jurisdictions, forming a global patent family.
- Effective monitoring is vital for patent owners to prevent infringement and defend market share.
- Stakeholders should continuously evaluate patent claims and landscape updates for strategic decisions.
5 FAQs
1. How do the claims define the patent's protection?
Claims specify the legal scope, usually covering a specific drug compound, formulation, or method. Their language determines how broadly the patent can be enforced.
2. What factors influence claim breadth?
Language specificity, whether claims describe formulas, ranges, or methods, influences breadth. Broader claims may risk invalidation; narrower claims offer focused protection.
3. How can competitors design around this patent?
By developing alternative formulations or methods that fall outside the scope of the claims, such as different chemical structures or delivery devices.
4. When will this patent expire?
Subject to maintenance and potential patent term adjustments, expected expiry is around 2043, 20 years from filing.
5. How does this patent interact with related patents?
It likely forms part of a patent family covering related compounds or formulations, expanding overall patent coverage and blocking potential alternative products.
References
- U.S. Patent and Trademark Office. (2023). Patent 11,383,059. Retrieved from USPTO patent database.
- USPTO. (2022). Patent Classification Chart. Retrieved from https://www.uspto.gov
- Merges, R. P., & Duffy, J. F. (2018). Patent Law and Practice. Aspen Publishers.
More… ↓
⤷ Start Trial
|
